# EDGAR Filing Document

**Accession Number:** 0000725363
**File Stem:** 0001654954-26-004301
**Filing Date:** 2026-5
**Character Count:** 2261
**Document Hash:** 99c2b30633d44be04b4ce7b85f6e7230
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-004301.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0001654954-26-004301

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260501

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEL SCI CORP
- **CENTRAL INDEX KEY:** 0000725363
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 840916344
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD .
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182
- **BUSINESS PHONE:** 7035069460

**MAIL ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD.
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERLEUKIN 2 INC
- **DATE OF NAME CHANGE:** 19880317

**ThinkEquity LLC**

**17 State Street, 41<sup>st</sup> Floor**

**New York, NY 10004**

May 1, 2026

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Cel-Sci Corporation Request for Acceleration** |
|  | **Registration Statement on Form S-1** |
|  | **File No. 333-295168 (the "Registration Statement")** |

---

Ladies and Gentlemen:

ThinkEquity LLC ("ThinkEquity"), acting as the sole placement agent on a best efforts basis in a public offering pursuant to the Registration Statement, hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on May 6, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act").

ThinkEquity affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

---

| |
|:---|
| Very truly yours, |
| **ThinkEquity LLC** |
| */s/ Eric Lord* |
| Eric Lord |
| Head of Investment Banking |

---